The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Inherited TP53 Mutations and the Li–Fraumeni Syndrome
Open accessAbstract
mutations is anticipated to shed light on this intriguing, yet devastating, disease and to transform the clinical management of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Self-citationSoft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome?
LI, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,509
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Multiple Primary Cancers in Families With Li-Fraumeni Syndrome
Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 557
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541
Olivier, M., Goldgar, D. E., Sodha, N., Ohgaki, H., Kleihues, P., Hainaut, P. L., & Eeles, R. A. (2003) · PubMed · Cited by 477
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475
Venkatachalam, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4657 · Cited by 449
Villani, A., Tabori, U., Schiffman, J., Shlien, A., Beyene, J., Druker, H., Novokmet, A., Finlay, J., & Malkin, D. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70119-x · Cited by 423
Self-citationPrevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., Harris, M., Jones, P. H. M., Binchy, A., & Crowther, D. (1994) · PubMed · Cited by 421
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1167 · Cited by 372
Ethical Issues With Genetic Testing in Pediatrics
Committee on Bioethics (2001) · Pediatrics · doi:10.1542/peds.107.6.1451 · Cited by 364
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols, K. E., Malkin, D. M., Garber, J. E., Fraumeni, J. F., & Li, F. P. (2001) · PubMed · Cited by 354
Self-citation2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Tinat, J., Bougeard, G., Baert-Desurmont, S., Vasseur, S., Martin, C., Bouvignies, E., Caron, O., Bressac-de Paillerets, B., Berthet, P., Dugast, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7967 · Cited by 348
Sensitivity and predictive value of criteria for p53 germline mutation screening
CHOMPRET, A., ABEL, A., STOPPA-LYONNET, D., BRUGIÈRES, L., PAGÈS, S., FEUNTEUN, J., & BONAÏTI-PELLIÉ, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.1.43 · Cited by 341
Liu, G., Parant, J. M., Lang, G., Chau, P., Chavez-Reyes, A., El-Naggar, A. K., Multani, A., Chang, S., & Lozano, G. (2004) · Nature Genetics · doi:10.1038/ng1282 · Cited by 325
TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
Tabori, U., Shlien, A., Baskin, B., Levitt, S., Ray, P., Alon, N., Hawkins, C., Bouffet, E., Pienkowska, M., Lafay-Cousin, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8169 · Cited by 247
Self-citationGermline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
Hwang, S.-J., Lozano, G., Amos, C. I., & Strong, L. C. (2003) · The American Journal of Human Genetics · doi:10.1086/374567 · Cited by 229
Wasserman, J. D., Novokmet, A., Eichler-Jonsson, C., Ribeiro, R. C., Rodriguez-Galindo, C., Zambetti, G. P., & Malkin, D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6863 · Cited by 227
Self-citationGemignani, F., Moreno, V., Landi, S., Moullan, N., Chabrier, A., Gutiérrez-Enríquez, S., Hall, J., Guino, E., Peinado, M. A., Capella, G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207305 · Cited by 217
Bougeard, G., Baert-Desurmont, S., Tournier, I., Vasseur, S., Martin, C., Brugieres, L., Chompret, A., Bressac-de Paillerets, B., Stoppa-Lyonnet, D., Bonaiti-Pellie, C., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.037952 · Cited by 217
Germline mutations in the TP53 gene.
Eeles, R. A. (1995) · PubMed · Cited by 211
Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome
Shlien, A., Tabori, U., Marshall, C. R., Pienkowska, M., Feuk, L., Novokmet, A., Nanda, S., Druker, H., Scherer, S. W., & Malkin, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802970105 · Cited by 203
Self-citationHigh metastatic potential in mice inheriting a targeted p53 missense mutation
Liu, G., McDonnell, T. J., Montes de Oca Luna, R., Kapoor, M., Mims, B., El-Naggar, A. K., & Lozano, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4174 · Cited by 199
Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice
Kuperwasser, C., Hurlbut, G. D., Kittrell, F. S., Dickinson, E. S., Laucirica, R., Medina, D., Naber, S. P., & Jerry, D. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64853-5 · Cited by 190
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation
Figueiredo, B. C., Sandrini, R., Zambetti, G. P., Pereira, R. M., Cheng, C., Liu, W., Lacerda, L., Pianovski, M. A., Michalkiewicz, E., Jenkins, J., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030551 · Cited by 166
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
Tabori, U. Y., Nanda, S., Druker, H. A., Lees, J., & Malkin, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3682 · Cited by 151
Self-citationLynch, H. T., Mulcahy, G. M., Harris, R. E., Guirgis, H. A., & Lynch, J. F. (1978) · Cancer · Cited by 140
Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers
Hettmer, S., Archer, N. M., Somers, G. R., Novokmet, A., Wagers, A. J., Diller, L., Galindo, C. R., Teot, L. A., & Malkin, D. M. (2013) · Cancer · doi:10.1002/cncr.28507 · Cited by 135
Self-citationCosta, S., Pinto, D., Pereira, D., Rodrigues, H., Cameselle‐Teijeiro, J., Medeiros, R., & Schmitt, F. C. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-32 · Cited by 114
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
Mai, P. L., Malkin, D. M., Garber, J. E., Schiffman, J. D., Weitzel, J. N., Strong, L. C., Wyss, O., Locke, L., Means, V., Achatz, M. I., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.06.008 · Cited by 105
Self-citationPla2g16 phospholipase mediates gain-of-function activities of mutant p53
Xiong, S., Tu, H., Kollareddy, M., Pant, V., Li, Q., Zhang, Y., Jackson, J. G., Suh, Y., Elizondo-Fraire, A. C., Yang, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404139111 · Cited by 103
The Inherited p53 Mutation in the Brazilian PopulationPreprint
Achatz, M. I., & Zambetti, G. P. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026195 · Cited by 99
Krutilkova, V., Trková, M., Fleitz, J. M., Gregor, V., Novotna, K., Křepelová, A., Sumerauer, D., Kodet, R., Širůčková, S., Plevová, P., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.026 · Cited by 97
Routine TP53 testing for breast cancer under age 30: ready for prime time?
McCuaig, J. M., Armel, S. R., Novokmet, A., Ginsburg, O., Demsky, R., Narod, S. A., & Malkin, D. M. (2012) · Familial Cancer · doi:10.1007/s10689-012-9557-z · Cited by 89
Self-citationClaes, E., Denayer, L., Evers‐Kiebooms, G., Boogaerts, A., & Legius, E. (2004) · Patient Education and Counseling · doi:10.1016/j.pec.2003.11.002 · Cited by 80
TP53Mutations in Hypodiploid Acute Lymphoblastic LeukemiaPreprint
Comeaux, E. Q., & Mullighan, C. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026286 · Cited by 79
Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
Lammens, C. R. M., Bleiker, E. M. A., Aaronson, N. K., Wagner, A., Sijmons, R. H., Ausems, M. G. E. M., Vriends, A. H. J. T., Ruijs, M., van Os, T. A. M., Spruijt, L., et al. (2010) · Familial Cancer · doi:10.1007/s10689-010-9368-z · Cited by 70
Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations
Vital, A., Bringuier, P., Huang, H., Galli, F. S., Rivel, J., Ansoborlo, S., Jm, C., Taillandier, L., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199811000-00009 · Cited by 56
Trková, M., Procházková, K., Krutilkova, V., Sumerauer, D., & Sedláček, Z. (2007) · Cancer · doi:10.1002/cncr.22834 · Cited by 55
A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome
Said, B. I., & Malkin, D. M. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.12.003 · Cited by 51
Self-citationVenneti, S., Hasselblatt, M., Wolff, J. E. A., & Judkins, A. R. (2014) · Molecular pathology library · doi:10.1007/978-1-4939-1830-0_12 · Cited by 41
Fang, S., Krahe, R., Lozano, G., Han, Y., Chen, W., Post, S. M., Zhang, B., Wilson, C. D., Bachinski, L. L., Strong, L. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010813 · Cited by 40
Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer
Vojtesek (2009) · Oncology Reports · doi:10.3892/or_00000556 · Cited by 27
Magnusson, S., Gisselsson, D., Wiebe, T., Kristoffersson, U., Borg, Å., & Olsson, H. L. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24223 · Cited by 25
Generation or birth cohort effect on cancer risk in Li–Fraumeni syndrome
Brown, B. W., Costello, T. J., Hwang, S., & Strong, L. C. (2005) · Human Genetics · doi:10.1007/s00439-005-0016-x · Cited by 23
Cited by
Arber, D. A., Orazi, A., Hasserjian, R. P., Borowitz, M. J., Calvo, K. R., Kvasnicka, H.-M., Wang, S. A., Bagg, A., Barbui, T., Branford, S., et al. (2022) · Blood · doi:10.1182/blood.2022015850 · Cited by 2,945
The Need for Multi-Omics Biomarker Signatures in Precision Medicine
Olivier, M., Asmis, R., Hawkins, G. A., Howard, T. D., & Cox, L. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194781 · Cited by 499
The p53 network: cellular and systemic DNA damage responses in cancer and aging
Vaddavalli, P. L., & Schumacher, B. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.010 · Cited by 279
Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0197 · Cited by 243
p53‐mediated adaptation to serine starvation is retained by a common tumour‐derived mutant
Humpton, T. J., Hock, A. K., Maddocks, O. D. K., & Vousden, K. H. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0191-6 · Cited by 58
Metadata
- Authors
- Guha, T., & Malkin, D.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-03-07
- Volume
- 7
- Issue
- 4
- Pages
- a026187
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2594796471
- Cited by
- 253
- References
- 53
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.